Similar Search Results

The impact of public basic research on industrial innovation : evidence from the pharmaceutical industry

Toole, Andrew A. - 2011 - This version: March 2011

While most economists believe that public scientific research fuels industry innovation and economic growth, systematic … size as a significant driver of drug innovation in the pharmaceutical industry, but they did not find any evidence … supporting science-driven innovation from publicly funded research. This paper uses new data on biomedical research investments …

Persistent link: https://www.econbiz.de/10009374417

Can Operation Warp Speed Serve as a Model for Accelerating Innovations Beyond COVID Vaccines?

D'Souza, Arielle; Hoyt, Kendall; Snyder, Christopher M.; … - National Bureau of Economic Research - 2024

Operation Warp Speed (OWS) was a U.S. government-led program to accelerate the development, production, and administration of COVID-19 vaccines. The program cut the typical ten-year timeline needed to develop a new vaccine down to ten months and began vaccinating vulnerable populations within a...

Persistent link: https://www.econbiz.de/10015056157

The future of pharmaceuticals : the changing environment for new drugs

Bezold, Clement - 1981

Persistent link: https://www.econbiz.de/10013490222

TRIPS flexibilities on patent enforcement : lessons from some developed countries relating to pharmaceutical patent protection

Sarnoff, Joshua D. - 2020

Persistent link: https://www.econbiz.de/10012433661

Calculating the Costs and Benefits of Advance Preparations for Future Pandemics

Glennerster, Rachel; Snyder, Christopher M.; Tan, … - National Bureau of Economic Research - 2022

The Covid-19 pandemic is estimated to have caused over 7 million deaths and reduced economic output by over $13 trillion to date. While vaccines were developed and deployed with unprecedented speed, pre-pandemic investments could have accelerated their widespread introduction, saving millions of...

Persistent link: https://www.econbiz.de/10013435127

Ex-Post Analysis of Pharmaceutical Merger Cases in the EU and US : The Identification of the Relevant R&D Projects

Laermann-Nguyen, Ute; Kerber, Wolfgang - 2023

definition carried out by the FTC and the European Commission with regard to innovation competition. In doing so, we selected … innovation. We compared the authorities' approaches to identifying competing R&D projects with data from an independent database … innovation competition …

Persistent link: https://www.econbiz.de/10014255748